quinazolines has been researched along with Hyperplasia in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.55) | 18.7374 |
1990's | 4 (18.18) | 18.2507 |
2000's | 8 (36.36) | 29.6817 |
2010's | 9 (40.91) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, XP; Hou, HH; Lin, SX; Sun, AS; Xu, Y; Zhang, F; Zhang, JY | 1 |
Arteaga, CL; Balko, JM; Cheng, H; Cook, RS; Kuba, MG; Owens, P; Perou, CM; Pfefferle, AD; Rexer, BN; Sánchez, V; Young, CD; Zhao, JJ | 1 |
Kwon, MJ; Lee, KB; Lee, MY; Lee, SH; Lee, YM; Nguyen, MP; Park, GH | 1 |
Bhagathavula, N; Dame, MK; Dawes, SM; Elder, JT; Fu, W; Gudjonsson, JE; Johnston, A; Lambert, S; Varani, J; Ward, NL; Warner, RL | 1 |
Cheng, NS; Li, FY; Ma, WJ; Mao, H; Shrestha, A; Yang, Q; Zhang, W; Zhou, Y | 1 |
Ichihara, E; Kiura, K; Kubo, T; Ohashi, K; Osawa, M; Takata, M; Takata, S; Takigawa, N; Tanimoto, M | 1 |
Hamid, Q; Hassan, M; Jo, T; Martin, JG; McGovern, T; Ramos-Barbón, D; Tamaoka, M; Tolloczko, B; Yoshizawa, Y | 1 |
Calabrò, E; De Marinis, F; Fabbri, A; Marchianò, A; Novello, S; Orsenigo, M; Pastorino, U; Sozzi, G; Tamborini, E | 1 |
Clowes, AW; Fukai, N; Jalikis, F; Kenagy, RD; Kohler, TR; Min, SK | 1 |
Chung, WC; Gold, KA; Hittelman, WN; Kang, SM; Ki Hong, W; Kim, ES; Koo, JS; Lee, J; Ryu, SH | 1 |
Bonanni, B; Decensi, A; Dotti, MC; Galimberti, V; Guerrieri-Gonzaga, A; Johansson, H; Lazzeroni, M; Luini, A; Macis, D; Pala, O; Pruneri, G; Puntoni, M; Serrano, D; Veronesi, P; Viale, G | 1 |
Abdulkadir, NA; Cetinkaya, M; Demirturk, K; Gur, S; Hellstrom, WJ; Karabakan, M; Ozgur-Akdemir, A; Volkan-Oztekin, C | 1 |
Gear, RB; Heffelfinger, SC; LaDow, K; Schneider, J; Warshawsky, D; Yan, M | 1 |
El-Abaseri, TB; Fuhrman, J; Hansen, LA; Shendrik, I; Tennant, RW; Trempus, C | 1 |
Akizawa, T; Hatamura, I; Negi, S; Orita, H; Saji, F; Sakaguchi, T; Shibata, M; Shiizaki, K | 1 |
Alvarez-Hernandez, D; Arcidiacono, MV; Cannata-Andia, J; Dusso, AS; Gonzalez-Suarez, I; Lu, Y; Sato, T; Slatopolsky, E; Tokumoto, M; Tominaga, Y; Yang, J | 1 |
Brown, DM; Callow, AD; Choi, ET; Ryan, US; Sehgal, NL | 1 |
Chmurzyńska, W; Grzelakowska-Sztabert, B; Manteuffel-Cymborowska, M | 1 |
Aingorn, H; Genina, O; Miao, HQ; Nagler, A; Pines, M; Vlodavsky, I | 1 |
Chmurzyńska, W; Dudkowska, M; Grzelakowska-Sztabert, B; Manteuffel-Cymborowska, M | 1 |
Bona, C; McGaha, TL; Phelps, RG; Spiera, H | 1 |
Baldwin, RW; Chayen, J; Diengdoh, JV | 1 |
1 trial(s) available for quinazolines and Hyperplasia
Article | Year |
---|---|
Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; ErbB Receptors; Female; Humans; Hyperplasia; Immunohistochemistry; In Situ Hybridization, Fluorescence; Ki-67 Antigen; Lapatinib; Middle Aged; Placebos; Prevalence; Quinazolines; Receptor, ErbB-2; Time Factors | 2011 |
21 other study(ies) available for quinazolines and Hyperplasia
Article | Year |
---|---|
Rutaecarpine Inhibits Intimal Hyperplasia in A Balloon-Injured Rat Artery Model.
Topics: Actins; Animals; Carotid Arteries; Carotid Artery Injuries; Cyclic GMP; Disease Models, Animal; Gene Expression Regulation; Hyperplasia; Indole Alkaloids; Male; Nitric Oxide; Phosphorylation; Proliferating Cell Nuclear Antigen; Quinazolines; Rats, Sprague-Dawley; RNA, Messenger; Tunica Intima | 2018 |
Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Female; Gene Expression; Humans; Hyperplasia; Lapatinib; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mice, Transgenic; Mutation, Missense; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Binding; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-3; Signal Transduction; Transcriptome; Tumor Burden | 2013 |
Silencing of reversion-inducing cysteine-rich protein with Kazal motifs stimulates hyperplastic phenotypes through activation of epidermal growth factor receptor and hypoxia-inducible factor-2α.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Hypoxia; Colony-Forming Units Assay; ErbB Receptors; Gefitinib; Gene Expression Regulation; Gene Knockdown Techniques; GPI-Linked Proteins; Hyperplasia; Mice; Mice, Nude; Phenotype; Quinazolines; RNA, Small Interfering | 2013 |
Erlotinib-induced skin inflammation is IL-1 mediated in KC-Tie2 mice and human skin organ culture.
Topics: Animals; Biopsy; Dermatitis; Disease Models, Animal; Dose-Response Relationship, Drug; Erlotinib Hydrochloride; Humans; Hyperplasia; In Vitro Techniques; Interleukin-1; Mice; Mice, Transgenic; Organ Culture Techniques; Phenotype; Quinazolines; Receptor, TIE-2; Skin | 2015 |
Effects of epidermal growth factor receptor inhibitor on proliferative cholangitis in hepatolithiasis.
Topics: Adult; Aged; Bile Ducts; Cholangitis; Collagen Type I; Endoscopy, Digestive System; Epithelium; ErbB Receptors; Female; Gefitinib; Gene Expression; Glucuronidase; Humans; Hyperplasia; Ki-67 Antigen; Lithiasis; Liver Diseases; Male; Middle Aged; Mucin-3; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Quinazolines | 2015 |
Effect of Vandetanib on Lung Tumorigenesis in Transgenic Mice Carrying an Activating Egfr Gene Mutation.
Topics: Animals; Antineoplastic Agents; Carcinogenesis; Carcinoma; ErbB Receptors; Gene Expression Regulation; Hyperplasia; Lung Neoplasms; Mice; Mice, Transgenic; Mutation; Piperidines; Quinazolines; Signal Transduction; Vascular Endothelial Growth Factor A | 2016 |
The epidermal growth factor receptor mediates allergic airway remodelling in the rat.
Topics: Allergens; Animals; Cell Proliferation; Cysteine; ErbB Receptors; Gene Expression Profiling; Goblet Cells; Hyperplasia; Inflammation; Leukotriene D4; Muscle, Smooth; Ovalbumin; Quinazolines; Rats; Receptors, Leukotriene; Tyrphostins | 2008 |
Prolonged remission of disseminated atypical adenomatous hyperplasia under gefitinib.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents; ErbB Receptors; Female; Gefitinib; Humans; Hyperplasia; Lung; Lung Neoplasms; Middle Aged; Mutation; Polymerase Chain Reaction; Quinazolines; Remission Induction; Tomography, X-Ray Computed | 2009 |
Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis.
Topics: Aged; Ankle; Becaplermin; Blood Pressure; Cell Proliferation; Cells, Cultured; Constriction, Pathologic; DNA Replication; Epidermal Growth Factor; Female; Fibroblasts; Graft Occlusion, Vascular; Heparin; Humans; Hyperplasia; Lower Extremity; Lysophospholipids; Male; Middle Aged; Myocytes, Smooth Muscle; Peripheral Vascular Diseases; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Quinazolines; Saphenous Vein; Sphingosine; Thrombin; Time Factors; Tyrphostins; Ultrasonography, Doppler, Duplex; Vascular Patency | 2009 |
Prevention of bronchial hyperplasia by EGFR pathway inhibitors in an organotypic culture model.
Topics: Bronchi; Butadienes; Cell Line, Tumor; Cyclin D1; Enzyme Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Humans; Hyperplasia; Luciferases; Lung Neoplasms; MAP Kinase Kinase Kinases; Models, Biological; Nitriles; Organ Culture Techniques; Quinazolines; RNA, Small Interfering | 2011 |
Imatinib mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue.
Topics: Adrenergic alpha-Antagonists; Aged; Benzamides; Humans; Hyperplasia; Imatinib Mesylate; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Piperazines; Prostate; Prostatic Diseases; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines | 2011 |
Inhibition of VEGFR2 prevents DMBA-induced mammary tumor formation.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Base Sequence; Carcinoma in Situ; DNA Primers; Female; Humans; Hyperplasia; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Piperidines; Quinazolines; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor Receptor-2 | 2004 |
Chemoprevention of UV light-induced skin tumorigenesis by inhibition of the epidermal growth factor receptor.
Topics: Animals; Anticarcinogenic Agents; Cell Proliferation; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Hyperplasia; MAP Kinase Signaling System; Mice; Mice, Nude; Neoplasms, Radiation-Induced; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines; Skin; Skin Neoplasms; Tyrphostins; Ultraviolet Rays | 2005 |
[Enhanced expression of EGFR, TGF-alpha, EGF in hyperplastic parathyroid glands in established stage of renal failure in rats].
Topics: Animals; Cell Proliferation; Disease Models, Animal; Epidermal Growth Factor; ErbB Receptors; Gefitinib; Hyperplasia; Intracellular Signaling Peptides and Proteins; Male; Parathyroid Glands; Parathyroid Hormone; Phosphorus, Dietary; Quinazolines; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Time Factors; Transforming Growth Factor alpha | 2005 |
EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.
Topics: Animals; Calcitriol; Carcinoma, Squamous Cell; CCAAT-Enhancer-Binding Protein-beta; Cell Line, Tumor; Disease Models, Animal; Drug Resistance; ErbB Receptors; Erlotinib Hydrochloride; Female; Genes, Reporter; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Renal Insufficiency, Chronic; Transforming Growth Factor alpha | 2008 |
Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intimal hyperplasia.
Topics: Anastomosis, Surgical; Animals; Blotting, Northern; Carotid Artery, Common; Cell Division; Cells, Cultured; Collagen; Dose-Response Relationship, Drug; Hyperplasia; Muscle, Smooth, Vascular; Piperidines; Procollagen; Quinazolines; Quinazolinones; Rabbits; RNA, Messenger; Tropoelastin; Tunica Intima | 1995 |
Polyamines in testosterone-induced hypertrophic and antifolate-induced hyperplastic mouse kidney. Differential effect of alpha-difluoromethylornithine.
Topics: Animals; Eflornithine; Female; Folic Acid; Hyperplasia; Hypertrophy; Kidney; Kidney Diseases; Mice; Organ Size; Ornithine Decarboxylase Inhibitors; Polyamines; Quinazolines; Testosterone | 1993 |
Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone.
Topics: Animals; Arteries; Cattle; Cell Division; Cells, Cultured; Collagen; Humans; Hyperplasia; Muscle, Smooth, Vascular; Piperidines; Quinazolines; Quinazolinones; Rabbits; Tunica Intima | 1997 |
Catecholamines participate in the induction of ornithine decarboxylase gene expression in normal and hyperplastic mouse kidney.
Topics: Animals; Catecholamines; Female; Folic Acid; Folic Acid Antagonists; Gene Expression; Hyperplasia; Kidney; Mice; Organ Size; Ornithine Decarboxylase; Quinazolines; Receptors, Catecholamine; Reserpine; RNA, Messenger | 1999 |
Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.
Topics: Animals; Cells, Cultured; Collagen; Collagen Type I; DNA-Binding Proteins; Fibroblasts; Gene Expression; Hyperplasia; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Mutant Strains; Piperidines; Quinazolines; Quinazolinones; Receptors, Transforming Growth Factor beta; Sclerosis; Signal Transduction; Skin; Skin Diseases; Smad3 Protein; Trans-Activators; Transforming Growth Factor beta | 2002 |
Histochemical comparison of the effects of a carcinogenic and a non-carcinogenic derivative of tricycloquinazoline.
Topics: Animals; Carcinogens; DNA; Electron Transport Complex IV; Glycerolphosphate Dehydrogenase; Histocytochemistry; Hyperplasia; L-Lactate Dehydrogenase; Mice; Neoplasms, Experimental; Phosphogluconate Dehydrogenase; Quinazolines; Skin; Skin Neoplasms; Succinate Dehydrogenase; Sulfhydryl Compounds | 1970 |